Iterum Therapeutics plc (ITRM)

NASDAQ: ITRM · IEX Real-Time Price · USD

1.570

+0.020 (1.29%)

At close: Apr 25, 2024, 3:59 PM

1.600

+0.030 (1.91%)

After-hours: Apr 25, 2024, 6:04 PM EDT

Iterum Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-38.37	-44.43	-91.56	-52.01	-103.13	-77.06	-29.41	-13.46
Depreciation & Amortization	1.75	1.8	2.1	0.16	0.15	0.14	0.07	0
Share-Based Compensation	0.78	4.76	4.32	2.76	2.17	1.29	0.39	0.35
Other Operating Activities	-3.49	19.4	69.3	-5.44	18.88	-1.62	-1.66	1.82
Operating Cash Flow	-39.33	-18.47	-15.84	-54.53	-81.92	-77.25	-30.6	-11.3
Capital Expenditures	-0.01	-0.06	-0.06	-0.01	-0.02	-0.09	-0.81	0
Change in Investments	23.35	14.02	-54.53	0	40.13	-8.57	-30.78	0
Investing Cash Flow	23.34	13.96	-54.6	-0.01	40.1	-8.66	-31.59	0
Share Issuance / Repurchase	1.03	0.43	89.64	69.96	3.1	75.52	0	0
Debt Issued / Paid	0	-2.25	-6.52	-5.49	-1.03	14.51	0	0
Other Financing Activities	-	-	-	-	-	32.18	45.87	20.85
Financing Cash Flow	1.03	-1.82	83.13	64.48	2.06	122.2	45.87	20.85
Exchange Rate Effect	-0.06	-0.05	0	-0.01	-0.02	-0.11	0	0
Net Cash Flow	-15.02	-6.38	12.69	9.93	-39.78	36.19	-16.32	9.55
Free Cash Flow	-39.34	-18.54	-15.9	-54.54	-81.95	-77.34	-31.42	-11.3
Free Cash Flow Margin	-	-	-	-	-221475.68%	-8900.12%	-6184.25%	-
Free Cash Flow Per Share	-3.04	-1.51	-1.46	-34.07	-84.67	-132.83	-2737.70	-7160.30

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).